A number of effective maintenance medication options exist for bipolar disorder (BD) and
these are regarded as the foundation of long-term treatment in BD. However, nonadherence …

Objective: In a phase 3 randomized double-blind placebo-controlled study, the authors
investigated the efficacy and safety of 42 mg/day of lumateperone in patients with bipolar I or …

Background Lithium remains first choice as maintenance treatment for bipolar affective
disorder. Yet, about half of all individuals may stop their treatment at some point, despite …

BackgroundAround 40% of people with bipolar disorder (BD) are non-adherent to
medication leading to relapse, hospitalisation and increased suicide risk. Limited progress …

Background Measuring the quality and performance of health care is a major challenge in
improving the efficiency of a health system. Patient experience is one important measure of …

Worldwide, the population is aging and this trend will increase in the future due to medical,
technological and scientific advancements. To take care of the elderly is highly demanding …

Purpose This study aimed to describe real-world treatment patterns and medication
adherence among patients with bipolar disorder (BD) in Japan. Patients and Methods Adult …

Individuals with mood disorders are predisposed to metabolic dysfunction, while those with
metabolic dysregulation such as diabetes and obesity experience more severe depressive …

Background: Despite the efficacy of treatment and severity of symptoms, medication
adherence by many with bipolar disorder (BD) is variable at best. This poses a significant …

Background: Poor adherence to treatment is one of the main challenges to symptom control
and preventing recurrence in bipolar disorder (BD). Numerous studies have established an …